Inactive Instrument
Immune Pharmaceuticals, Inc. Stock
Stocks
FZRQ
US45254C2008
Pharmaceuticals
OTC Markets Traded| 1 day | +300.00% |
| Manager | Title | Age | Since |
|---|---|---|---|
Devin J. Shaw
DFI | Director of Finance/CFO | 39 | 13/04/2021 |
John Zhang
CTO | Chief Tech/Sci/R&D Officer | - | 11/12/2017 |
Boris Shor
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Sidransky
BRD | Director/Board Member | 66 | 26/08/2013 |
Daniel Kazado
CHM | Chairman | 61 | 10/10/2013 |
John A. Neczesny
BRD | Director/Board Member | 62 | 02/02/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 03/02/20 | Sell | Director | 75,000 | 0.0412% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +300.00% | -.--% | - | - | 386K | |
| +0.43% | +6.59% | +56.57% | +107.01% | 1,120B | |
| +0.90% | -2.25% | +32.26% | +67.33% | 616B | |
| +0.71% | +3.24% | +24.33% | +91.20% | 504B | |
| -0.13% | +5.98% | +33.66% | +52.01% | 367B | |
| +0.52% | +0.24% | +72.13% | +43.10% | 360B | |
| -0.95% | +4.70% | +19.65% | +43.09% | 288B | |
| -1.98% | +3.73% | -0.89% | +17.28% | 258B | |
| -0.35% | +4.25% | +44.74% | +52.51% | 234B | |
| -0.75% | +3.32% | +27.18% | +96.05% | 194B | |
| Average | +29.84% | +3.61% | +34.40% | +63.29% | 437.88B | |
| Weighted average by Cap. | +0.13% | +3.83% | +39.34% | +73.52% |
Employees
7
Sector
Pharmaceuticals
